Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.
about
Evolutionary rescue: linking theory for conservation and medicineOptimal drug synergy in antimicrobial treatmentsModeling of the bacterial mechanism of methicillin-resistance by a systems biology approach"One-size-fits-all"? Optimizing treatment duration for bacterial infectionsTwo-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinumA trade-off between the fitness cost of functional integrases and long-term stability of integronsSynergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureusThe pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulationsA population model evaluating the consequences of the evolution of double-resistance and tradeoffs on the benefits of two-drug antibiotic treatmentsSpatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapyQuantifying the Determinants of Evolutionary Dynamics Leading to Drug ResistanceIntegrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive TreatmentAntimicrobial Susceptibility of Enteric Gram Negative Facultative Anaerobe Bacilli in Aerobic versus Anaerobic ConditionsPopulation Density Modulates Drug Inhibition and Gives Rise to Potential Bistability of Treatment Outcomes for Bacterial InfectionsA multi-scale approach to designing therapeutics for tuberculosisA computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatmentPersistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibioticsClassic reaction kinetics can explain complex patterns of antibiotic action.Transitioning from First Drug Use to Dependence Onset: Illustration of a Multiparametric Approach for Comparative EpidemiologyThe development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populationsExploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infectionsThe evolution of plasmid-carried antibiotic resistance.Population dynamics of antibiotic treatment: a mathematical model and hypotheses for time-kill and continuous-culture experiments.Staphylococcus aureus in continuous culture: a tool for the rational design of antibiotic treatment protocolsPharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureusQuantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus.Pharmacokinetic-pharmacodynamic model to evaluate intramuscular tetracycline treatment protocols to prevent antimicrobial resistance in pigs.How fitness reduced, antimicrobial resistant bacteria survive and spread: a multiple pig-multiple bacterial strain model.Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo EfficaciesCombination Effects of Antimicrobial Peptides.Antimicrobial combinations: Bliss independence and Loewe additivity derived from mechanistic multi-hit models.The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilmsModeling the growth dynamics of multiple Escherichia coli strains in the pig intestine following intramuscular ampicillin treatment.Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeaePharmacodynamic modelling of in vitro activity of tetracycline against a representative, naturally occurring population of porcine Escherichia coli.Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae
P2860
Q26862297-D7E33744-82E5-41EB-AE8D-3066CE32DB7EQ28474170-8FEEFB58-4F41-4C2C-A0E4-1273126D5AB9Q28475777-5A7A5BD5-81B0-4590-9DB1-D73E61E461F4Q28478851-B880E0BF-844A-403E-9F48-4567806F4679Q28478890-836CF0B9-2030-4076-A259-47EF2762EB58Q28485389-BFCF05A4-13C4-4B0F-B03B-798653DBAE9FQ28485429-7D91E3CE-CD8A-47C0-8367-8B9DF109201EQ28485988-83885C4E-A0C8-4E55-B15C-58330D782730Q28539364-0957E5E8-25B5-477A-B2BB-9B076BD33974Q28544732-2BC878A9-FD8C-4EC2-B906-D515328C94F2Q28551034-9E206FB5-99FC-47BB-B33C-9A6867DD1522Q28551361-A55EC915-8DCE-4F1F-900D-842B2B9DEE6AQ28552167-BD107CF3-AB56-4D7E-B639-2F3B7ED06D9EQ28552830-1D7360A3-0E99-4DB7-B13E-EBEA150446C0Q28647309-1C025BB9-5BB9-41CA-A0F0-7D12ABC82DBCQ28649754-BAB6FC4E-A2B4-4382-AFE1-7573110100B8Q30604367-129E21B2-BD81-46A7-A6E3-59C87525EE61Q30662980-380EB296-2766-4AB7-9361-EB399856F7F7Q30697158-5C60AFDD-1906-4AFD-8777-A09B2490A02DQ33653162-722A523C-79C6-4E2E-B73A-2D6CA60D8490Q33722011-2E6A2516-665C-4F96-9B89-833290B6E51CQ33767602-4B1836D0-9A08-458D-ABA5-2F8D20C62CAEQ33905942-AFD603CB-FD8B-4D3F-A8E9-A498FEE4B15EQ34045319-F4664536-9C27-4A39-BB4F-2B49F1121610Q34387384-1D13EDA2-7841-47AF-86F2-B65F9861FB93Q34539889-6EFE6F1A-1308-4EE1-A272-CF1D6C08D689Q34573964-30100520-0EE0-4ADC-A304-B3AD0A1BC01CQ34922570-A859DEF5-0655-4C90-897A-8B53907058C8Q35023303-B9DCFEA0-2585-48F0-B2DE-53AEDC3C94D7Q35076904-C5676F03-F89B-4F40-83CB-D79B9C56E76AQ35203684-A7B6A7CD-82CA-4304-9565-078FB49189E2Q35635652-6F240625-CD31-4AF9-9AC2-D1159BC961FAQ35823020-6A023224-8109-440C-9C62-17653F20C4A7Q35884844-3A2F5F21-C626-4CFD-9CF0-788F06207C1FQ36012629-EC6B7E58-90F1-4C6D-A789-873DBAAD9989Q36018792-659700C2-17A5-47B6-8CFF-1613BED2CFCCQ36124204-C516BDEB-8B0E-48D6-BA96-44ADB8DE38C4Q36136318-97CAF070-3DD8-48E8-BD73-9066256CB35CQ36310839-65C80396-3D4A-4371-B8F3-F54978028148Q36360329-71AD6B97-BC5E-48FD-B205-719900712711
P2860
Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacodynamic functions: a m ...... antibiotic treatment regimens.
@en
Pharmacodynamic functions: a m ...... antibiotic treatment regimens.
@nl
type
label
Pharmacodynamic functions: a m ...... antibiotic treatment regimens.
@en
Pharmacodynamic functions: a m ...... antibiotic treatment regimens.
@nl
prefLabel
Pharmacodynamic functions: a m ...... antibiotic treatment regimens.
@en
Pharmacodynamic functions: a m ...... antibiotic treatment regimens.
@nl
P2093
P2860
P1476
Pharmacodynamic functions: a m ...... antibiotic treatment regimens.
@en
P2093
Bruce R Levin
Camilla Wiuff
Fernando Baquero
Kim N Garner
Renata M Zappala
Roland R Regoes
P2860
P304
P356
10.1128/AAC.48.10.3670-3676.2004
P407
P577
2004-10-01T00:00:00Z